AstraZeneca Takes Out Antibiotic Firm Novexel, With Cash Back from Forest

AZ will pay up to $505 million and split antibiotic cocktail rights with Novexel partner Forest, which in turn will pay more than $200 million to AZ.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet